SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

$DOG.X is trending as a Bitcoin-native meme coin, emphasizing its fair launch and strong community, known as the #DOGArmy. Community members highlight its integration with the Bitcoin network, and some suggest it could outperform other meme coins. There is also discussion around potential exchange listings and price targets.

Memecoin on Injective taken over by the community.

Nonja

$NONJA.X is trending as community members highlight its strong community, unique art, and potential for amplified gains as a meme coin on the Injective chain ($INJ.X). The community is closely watching for potential catalysts, including a possible staked $INJ.X ETF, which could further boost $NONJA.X.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is trending as investors anticipate the results from the global Phase III HARMONi clinical trial for Ivonescimab, which will be presented at the World Conference on Lung Cancer. Community discussions revolve around the potential for positive Overall Survival (OS) data, particularly for Western patients, and speculation about a possible Biologics License Application (BLA) filing. Some traders are also discussing the possibility of a large licensing deal with AstraZeneca, which could be a catalyst for significant upside.

Gyrodyne LLC engages in the management of a portfolio of medical office and industrial properties. Its properties include Flowerfield, Port Jefferson Professional Park, Courtland Medical Center, and Grove. The company was founded by Peter James Papadakos in 1946 and is headquartered in St. James, NY.

Gyrodyne LLC

GYRO is trending due to a potential catalyst related to the company's land assets and a planned liquidation, sparking speculation of a significant value unlock. The stock's low float is fueling discussions about potential for a rapid price surge, with some traders eyeing a run back to previous highs. Community members are closely monitoring volume and key breakout levels, anticipating a possible squeeze.

ProShares Trust - ProShares Short Dow30 -1x Shares

ProShares Short Dow30

$DOG is trending as community members rally around its potential to become the leading memecoin on the Bitcoin network, with some suggesting it could surpass Dogecoin. Key talking points include its fair launch, decentralized nature, and strong community backing. Many believe it's poised for significant growth and exchange listings.

Numeraire

Numeraire is trending as traders discuss a potential investment from a major US bank, which the community believes could significantly increase the token's value. Community members are closely watching key price levels, anticipating a breakout and further upward movement. The coin's AI narrative and low circulating supply contribute to the bullish sentiment.

WorldFinancial

WorldFinancial (WLFI.X) is trending amid community discussions about its potential as a top DeFi platform and speculation around large buy orders. The coin's strong chart patterns and technical validation are being actively discussed, with some anticipating a rise. Broader market interest is fueled by its association with real-world asset tokenization.

Infinite Money Glitch ($IMG) is revolutionizing DeFi on Solana by leveraging the Token2022 program's advanced tax extension capabilities to create a truly innovative reward system for token holders.  At its core, $IMG implements a seamless 5% tax on all transactions - whether buying, selling, or transferring tokens. This tax is automatically collected and distributed to holders in SOL, creating a sustainable passive income stream for the community. 4.5% of the tax gets sent to holders, while .5% gets sent to an Infrastructure wallet to help with development, marketing and general infrastructure.  What sets $IMG apart is its implementation of Solana's Token2022 program, enabling automated and efficient reward distribution without relying on external smart contracts.

Infinite Money Glitch

IMG.X is trending as community members highlight the consistent $SOL rewards distributed to holders, emphasizing it as a unique DeFi savings account. Discussions revolve around the strength and resilience of the community, which has supported the project through challenges. Many believe IMG.X offers a compelling alternative to traditional finance, rewarding conviction and long-term holding.

Bed Bath & Beyond, Inc. engages in the provision of an e-commerce platform. It offers furniture and home furnishing products and services. The company was founded on May 5, 1997 and is headquartered in Murray, UT.

Bed Bath & Beyond Inc.

Bed Bath & Beyond Inc

Bed Bath & Beyond ($BBBY) is trending as traders discuss the reactivation of the ticker following Beyond, Inc.'s acquisition of its intellectual property, with some speculating about potential partnerships and short squeezes. The community is also debating the implications for former BBBYQ shareholders and the potential for tokenizing the stock. Bullish sentiment is fueled by discussions around blockchain applications and memories of previous squeezes.

Lear Corp. engages in the design, manufacture and supply of automotive seats, electrical distribution systems and electronic modules, as well as related sub-systems, components, and software. It operates through the following segments: Seating and E-Systems. The Seating segment consists of the design, engineering, just-in-time assembly and delivery of complete seat systems, as well as the manufacture of all major seat components, including seat covers and surface materials such as leather and fabric, seat structures and mechanisms, seat foam and headrests. The E-System segment engages in the design, development, engineering and manufacture of electrical distribution systems, as well as electronic control modules, electrification products, connectivity products and software solutions for the cloud, vehicles and mobile devices. The company was founded in 1917 and is headquartered in Southfield, MI.

Lear Corp.

Lear Corp. is trending following Q2 earnings, which beat expectations, and updated guidance. The community is focused on the company's partnership with Palantir, as well as revenue and EPS growth. Analysts are updating their ratings and price targets.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Tvardi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need. The company was founded in 2017 and is headquartered in Sugar Land, TX.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	-$1.00	--	--	N/A
Q2 '25	-$0.68	-$1.00	-46.40%	MISSED
Q1 '25	--	-$3.22	--	N/A
Q1 '24	--	-$20.16	--	N/A
Q3 '23	-$0.51	--	--	N/A

TVRD
Tvardi Therapeutics, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q2 '25

Historical Earnings

Latest TVRD News

TVRD Tvardi Therapeutics, Inc.